• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Ophthonix upgrades to larger facility

Article

Ophthonix Inc. has moved its headquarters effective Sept. 17 to accommodate growth in business and operations.

Vista, CA-Ophthonix Inc. has moved its headquarters effective Sept. 17 to accommodate growth in business and operations.

The company relocated from Sorrento Valley, CA, to a 45,000-sq. ft. facility in Vista. The new facility is more than double the previous space at Pacific Center Court, and will house both corporate offices and a much larger manufacturing operation.

Stephen Osbaldeston, chief executive officer of Ophthonix, said, "The new facility will provide optimum space for an advanced, fully automated optical lab and will enable us to meet increasing customer demand for many years to come."

Related Videos
© 2024 MJH Life Sciences

All rights reserved.